24 results on '"Parellada, E."'
Search Results
2. Birth weight, leptin and adiponectin in patients initiating clozapine.
3. Delayed post-hypoxic leukoencephalopathy: Case report
4. Real-world paliperidone palmitate data from acute units: The SHADOW study
5. Palmitate de palipéridone chez des patients atteints de schizophrénie, non-aigus mais symptomatiques, après échec d’un traitement par aripiprazole
6. EPA-1551 - Paliperidone palmitate – impact on negative, disorganized and depressive symptoms, subjective well-being and patient satisfaction in patients with schizophrenia previously unsuccessfully treated with oral antipsychotics
7. EPA-1545 - Functional outcomes with once-monthly paliperidone palmitate in acute and in non-acute patients with schizophrenia previously unsuccessfully treated with oral antipsychotics
8. EPA-1547 - Once monthly paliperidone palmitate – tolerability and treatment response in recently diagnosed versus chronic non-acute schizophrenia patients switched from previously unsuccessful treatment with oral antipsychotics
9. EPA-1546 - Paliperidone palmitate in non-acute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral aripiprazole
10. EPA-1548 - Flexibly dosed paliperidone palmitate in non-acute patients with schizophrenia switched from previously unsuccessful monotherapy with oral atypical antipsychotics
11. EPA-1241 – Clinical use of spect datscan in psychiatric population: one-year outcomes of a prospective case series
12. EPA-1550 - Paliperidone palmitate in acute patients with schizophrenia: treatment response, safety and tolerability ? a prospective flexible-dose study in patients previously unsuccessfully treated with oral antipsychotics
13. Réponse thérapeutique, tolérance et sécurité d’emploi du palmitate de palipéridone à dose flexible : une étude prospective chez des patients adultes non-aigus atteints de schizophrénie, après échec d’un traitement par antipsychotiques oraux
14. Amélioration fonctionnelle sous palmitate de paliperidone à doses flexibles chez des patients aigus ou non aigus atteints de schizophrénie, après échec d’un traitement par antipsychotiques oraux
15. Palmitate de palipéridone à doses flexibles chez des patients non-aigus atteints de schizophrénie après échec d’un autre traitement par antipsychotiques injectables à action prolongée
16. Palmitate de palipéridone à doses flexibles – Réponse thérapeutique, tolérance et sécurité d’emploi: une étude prospective chez des patients en période d’exacerbation aiguë d’un trouble schizophrénique après échec d’un traitement par antipsychotiques oraux
17. P-1210 - Comparative study of the effectiveness of long acting injectable risperidone in front of oral antipsychotics in early onset schizophrenia
18. Remission and functioning after two years undergoing Long-Acting Injectable Risperidone (LAIR) in recent-onset schizophrenia
19. Survey of Safety and Efficacy of Long-acting Injectable Risperidone in Daily Practice: An Open-label, Non-interventional Prospective Study
20. Does culture influence psychotic presentations? A chinese case report.
21. A mexican werewolf in barcelona: clinical lycanthropy due to cerebellar lesion and hydrocephalus.
22. P03-175 - Remission and functioning after two years undergoing Long-Acting Injectable Risperidone (LAIR) in recent-onset schizophrenia
23. P03-26 Survey of safety and efficacy of long-acting injectable risperidone in daily practice: An open-label, non-interventional prospective study
24. Thyrotoxic psychosis: when things don't match.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.